Califorrniaa v. Vidal

CourtCourt of Appeals for the Federal Circuit
DecidedNovember 7, 2022
Docket22-1640
StatusUnpublished

This text of Califorrniaa v. Vidal (Califorrniaa v. Vidal) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Califorrniaa v. Vidal, (Fed. Cir. 2022).

Opinion

Case: 22-1640 Document: 36 Page: 1 Filed: 11/07/2022

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

EURICA CALIFORRNIAA, Plaintiff-Appellant

v.

KATHERINE K. VIDAL, UNDER SECRETARY OF COMMERCE FOR INTELLECTUAL PROPERTY AND DIRECTOR OF THE UNITED STATES PATENT AND TRADEMARK OFFICE, Defendant-Appellee ______________________

2022-1640 ______________________

Appeal from the United States District Court for the Eastern District of Virginia in No. 1:20-cv-00985-MSN- TCB, Judge Michael S. Nachmanoff. ______________________

Decided: Nov. 7, 2022 ______________________

EURICA CALIFORRNIAA, Mahopac, NY, pro se.

DANA KAERSVANG, Appellate Staff, Civil Division, United States Department of Justice, Washington, DC, for defendant-appellee. Also represented by BRIAN M. BOYNTON, DANIEL TENNY; JESSICA D. ABER, MEGHAN LOFTUS, Office of the United States Attorney for the Case: 22-1640 Document: 36 Page: 2 Filed: 11/07/2022

Eastern District of Virginia, United States Department of Justice, Alexandria, VA; KAKOLI CAPRIHAN, BENJAMIN T. HICKMAN, THOMAS W. KRAUSE, BRIAN RACILLA, FARHEENA YASMEEN RASHEED, Office of the Solicitor, United States Patent and Trademark Office, Alexandria, VA. ______________________

Before LOURIE, DYK, and HUGHES, Circuit Judges. PER CURIAM. Eurica Califorrniaa appeals from the decision of the United States District Court for the Eastern District of Vir- ginia granting summary judgment in favor of the United States Patent and Trademark Office (“PTO”). See Califorr- niaa v. Hirshfeld, No. 1-20-cv-00985, 2021 WL 6196996 (E.D. Va. Dec. 20, 2021). We affirm. BACKGROUND Califorrniaa alleges that the PTO incorrectly calcu- lated the Patent Term Adjustment (“PTA”) for his patent, U.S. Patent 10,245,075 (the “’075 patent”), by improperly deducting 51 days due to applicant delay. Patent terms are generally extended by one day for each day of PTO delay, minus one day for each day during which the applicant fails to engage in reasonable efforts to conclude prosecution of the application. 35 U.S.C. § 154(b)(2)(C). 1 Congress delegated to the PTO the

1 35 U.S.C. § 154(b)(2)(C): Reduction of period of ad- justment. — (i) The period of adjustment of the term of a patent un- der paragraph (1) shall be reduced by a period equal to the period of time during which the applicant failed to engage in reasonable efforts to conclude prosecution of the appli- cation. Case: 22-1640 Document: 36 Page: 3 Filed: 11/07/2022

CALIFORRNIAA v. VIDAL 3

authority to define those situations that reflect a failure to engage in reasonable efforts to conclude prosecution of the patent. § 154(b)(2)(C)(iii). To avoid case-by-case de- terminations of what constitutes a failure to engage in reasonable efforts to conclude prosecution, it has promul- gated regulations outlining examples of such efforts. See 65 Fed. Reg. 56366, 56378–79 (Sept. 18, 2000). It has de- fined an applicant’s amendment of a patent application after it issues a notice of allowance as one such failure. 37 C.F.R. § 1.704(c)(10). 2 Following our January 23, 2019

(ii) With respect to adjustments to patent term made under the authority of paragraph (1)(B), an applicant shall be deemed to have failed to engage in reasonable efforts to conclude processing or examination of an application for the cumulative total of any periods of time in excess of 3 months that are taken to respond to a notice from the Office making any rejection, objection, argument, or other re- quest, measuring such 3-month period from the date the notice was given or mailed to the applicant. (iii) The Director shall prescribe regulations establish- ing the circumstances that constitute a failure of an appli- cant to engage in reasonable efforts to conclude processing or examination of an application. 2 37 C.F.R. § 1.704(c)(10) (2019): Submission of an amendment under § 1.312 or other paper, other than a re- quest for continued examination in compliance with § 1.114, after a notice of allowance has been given or mailed, in which case the period of adjustment set forth in § 1.703 shall be reduced by the lesser of: (i) The number of days, if any, beginning on the date the amendment under § 1.312 or other paper was filed and ending on the mailing date of the Office action or notice in response to the amendment under § 1.312 or such other pa- per; or (ii) Four months. Case: 22-1640 Document: 36 Page: 4 Filed: 11/07/2022

decision in Supernus, the PTO revised its regulations gov- erning the calculation of PTA, including § 1.704(c)(10). Supernus Pharms., Inc. v. Iancu, 913 F.3d 1351 (Fed. Cir. 2019); 85 Fed. Reg. 36335, 36335 (June 16, 2020). This subsection was amended in June 2020 to (1) distinguish between after-allowance amendments expressly requested by the PTO, and those not, and (2) change the relevant timeframe for the calculation of a reduction in PTA. 37 C.F.R. § 1.704(c)(10) (2020) 3; 85 Fed. Reg. at 36335. After an extensive prosecution involving numerous amendments, the examiner found that Califorrniaa’s pa- tent could issue if minor additional changes were made to the claim language. C.A. 101–03. 4 The examiner made the amendment on his own authority and mailed the Notice of Allowance on December 11, 2018. C.A. 100. On January 7, 2019, Califorrniaa requested an additional interview, at- taching a new proposed amendment to the interview re- quest. C.A. 112–16. The interview was held the following day and included discussion of the potential amendment. Id. On January 10, 2019, Califorrniaa accordingly submit- ted a new amendment making minor changes (e.g., the ad- dition of a comma) to some of the examiner-amended claim limitations, and several substantive changes (e.g., the

3 37 C.F.R. § 1.704(c)(10) (2020): Submission of an amendment under § 1.312 or other paper, other than an amendment under § 1.312 or other paper expressly re- quested by the Office or a request for continued examina- tion in compliance with § 1.114, after a notice of allowance has been given or mailed, in which case the period of ad- justment set forth in § 1.703 shall be reduced by the num- ber of days, if any, beginning on the day after the date of mailing of the notice of allowance under 35 U.S.C. 151 and ending on the date the amendment under § 1.312 or other paper was filed. 4 “C.A.” refers to Appellee’s Corrected Appendix. Case: 22-1640 Document: 36 Page: 5 Filed: 11/07/2022

CALIFORRNIAA v. VIDAL 5

deletion of limitations) unrelated to the examiner amend- ment. C.A. 117–36. On February 26, 2019, the examiner responded and accepted the amendment. C.A. 140–161. The patent issued on April 2, 2019. C.A. 162. The PTO, in calculating PTA, subtracted 51 days for the time that the plaintiff's after-allowance amendment was pending pursuant to 37 C.F.R. § 1.704(c)(10) (2019). At the time of calculation, § 1.704(c)(10) required a reduc- tion of PTA for “[s]ubmission of an amendment under § 1.312 . . .

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Norfolk Southern Railway Co. v. City of Alexandria
608 F.3d 150 (Fourth Circuit, 2010)
Gilead Sciences, Inc. v. Lee
778 F.3d 1341 (Federal Circuit, 2015)
Supernus Pharmaceuticals, Inc. v. Iancu
913 F.3d 1351 (Federal Circuit, 2019)
Intra-Cellular Therapies, Inc v. Iancu
938 F.3d 1371 (Federal Circuit, 2019)
Chudik v. Hirshfeld
987 F.3d 1033 (Federal Circuit, 2021)

Cite This Page — Counsel Stack

Bluebook (online)
Califorrniaa v. Vidal, Counsel Stack Legal Research, https://law.counselstack.com/opinion/califorrniaa-v-vidal-cafc-2022.